Today: 19 April 2026
Sembcorp Industries share price: what to watch after Friday dip as Feb 25 results near
7 February 2026
2 mins read

Sembcorp Industries share price: what to watch after Friday dip as Feb 25 results near

Singapore, Feb 7, 2026, 15:23 SGT — The market has closed.

  • Sembcorp shares finished at S$6.05, slipping 0.33%. Singapore’s STI dropped 0.8% on Friday.
  • The company has scheduled its FY2025 results for Feb 25, set to release before the market opens.
  • On Jan 30, shareholders gave the green light to the planned takeover of Australia’s Alinta Energy during an extraordinary meeting.

Sembcorp Industries Ltd (SGX: U96) slipped 0.33% to finish Friday at S$6.05, with the stock moving in a narrow S$6.00-S$6.05 band. Volume landed at roughly 4.3 million shares.

Heading into Monday, the stock faces two key catalysts that could quickly shift sentiment: upcoming full-year results later this month, plus updates on the company’s planned Australia expansion through Alinta Energy.

The decline on Friday coincided with a downturn across Singapore stocks. According to The Business Times, the Straits Times Index gave up 0.8%, ending a streak of three straight record closes.

Sembcorp will hold its FY2025 results briefing on Feb 25, kicking off a live webcast at 11:00 a.m. GMT+8.

So, for traders hoping to keep things tight in the name, the next couple sessions could get tricky. Most of the major questions are packed into a single document.

At an extraordinary general meeting on Jan 30, shareholders signed off on the proposed acquisition, with 99.76% of votes backing the plan, according to a filing. But the company noted that the deal isn’t done yet; other conditions precedent remain in play, and those hurdles must be cleared before closing. The cut-off date is nine months after the share sale agreement.

Sembcorp, in its meeting presentation, outlined plans to pay for the deal using a fully committed A$6.5 billion bridge facility—a short-term loan meant to cover the purchase until longer-term financing is arranged. The company noted there’s no need for equity fundraising. Closing is penciled in for the first half of 2026, pending shareholder and regulatory green lights, plus standard closing hurdles.

Back in December, Reuters said Temasek-backed Sembcorp had struck a deal to acquire Alinta Energy, valuing the business at A$6.5 billion enterprise-wide. The move brings Sembcorp roughly 1.1 million extra customers and 3.4 gigawatts of generation spanning gas, coal, wind, and solar. According to Sembcorp, the transaction should be immediately earnings-accretive—boosting profit per share right away. The company projected a 9% gain in pro-forma 2024 earnings per share, essentially a “what-if” scenario as if the Alinta deal had already closed. Reuters

This isn’t a straightforward transaction, and management hasn’t pretended otherwise. Group CEO Wong Kim Yin told The Business Times the move hands Sembcorp “a strong position in a key developed market,” plus a springboard for growth in renewables and low-carbon solutions. On the flipside, the company warned the acquisition will push up emissions in the near term, meaning it won’t hit its 2028 emissions intensity or 2030 absolute emissions targets. The Business Times

Sembcorp, addressing shareholder questions before the meeting, said Alinta is expected to boost cash flow after factoring in maintenance capex and debt payments. The company also pointed to stronger cash flows from the expanded portfolio, saying these would aid deleveraging and help ensure “sustainable shareholder returns.” Sembcorp

Singapore’s market is quiet for the weekend, so focus moves to Monday, Feb 9, ahead of the Feb 25 results. Investors are watching for any word on funding, regulatory approvals, or when the Alinta deal might close—details that could sway Sembcorp shares as the month winds down.

Stock Market Today

  • Brown-Forman (BF.B) Faces Valuation Debate After Strong Short-Term Rally
    April 18, 2026, 9:26 PM EDT. Brown-Forman's (BF.B) stock surged about 27% in one month, reversing last year's roughly 11% decline. The recent sharp rebound contrasts with a weaker long-term trend, highlighting momentum shifts. Despite shares trading near analyst price targets at $29.15, fair value estimates diverge widely. Simply Wall St's discounted cash flow (DCF) model values Brown-Forman at $37.78, suggesting undervaluation, while another model pegs fair value at $21.00, indicating the stock is roughly 39% overvalued. The gap reflects differing views on declining global alcohol consumption due to rising health awareness, which could pressure Brown-Forman's revenue growth. However, premium spirits and emerging market demand might offset some risks. Investors face critical decisions amid mixed signals, weighing whether current prices embed growth prospects or overestimate future earnings.

Latest article

Why Definium Therapeutics’ LSD-Based Drug Has Wall Street Watching 2026

Why Definium Therapeutics’ LSD-Based Drug Has Wall Street Watching 2026

18 April 2026
Definium Therapeutics shares rose to $22.68 after Stifel and Piper Sandler initiated coverage with Buy ratings, citing late-stage trials of DT120, an LSD-based tablet for anxiety and depression. The company will host an investor day April 22 in New York to discuss upcoming Phase 3 data. DT120 is in four pivotal studies, with top-line results expected through 2026. Johnson & Johnson and Compass Pathways are advancing rival clinic-based psychiatric drugs.
Xero share price slides 14% in a week — what to watch next for ASX:XRO
Previous Story

Xero share price slides 14% in a week — what to watch next for ASX:XRO

GSK share price set for Monday watch after EU clears Nucala COPD use
Next Story

GSK share price set for Monday watch after EU clears Nucala COPD use

Go toTop